
|Articles|August 13, 2008
Viread now also approved to treat hepatitis B
The drug is administered as a once-daily tablet.
Advertisement
The anti-HIV drug Viread (tenofovir disoproxil fumarate, Gilead Sciences) has gained a new indication: to treat chronic hepatitis B in adults. Administered as a once-daily tablet, the
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
2
Q&A: Pharmacists Can Address ADA Standards Across All Settings
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
5





























































